Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Readers Comments

Back to Item »

FDA Gives Amgen’s Prolia the Go-Ahead in Two Cancer Therapy-Induced Bone Loss Indications

Sanction covers use of drug to increase bone mass in patients with prostate or breast cancer undergoing hormone ablation therapy.

0 Readers' Comments
  • Click here to Login or to Register for free.

    You will be taken back to your selected item after Login/Registration.

GEN Poll

More » Poll Results » Archive »

GEN’s Hall of Shame

Will you be voting for any of the candidates on GEN’s Hall of Shame list in the next election?

Suggest a Poll